Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

PHASE3CompletedINTERVENTIONAL
Enrollment

933

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

Placebo

Once daily, matching placebo capsules, orally

DRUG

Idalopirdine

Once daily, encapsulated tablets, orally

Trial Locations (137)

Unknown

US027, Birmingham

US012, Phoenix

US024, Little Rock

US053, Glendale

US023, Imperial

US015, La Jolla

US045, Long Beach

US002, Los Angeles

US058, San Francisco

US018, Santa Ana

US060, Denver

US042, Boca Raton

US021, Bradenton

US050, Brooksville

US019, Orlando

US038, Port Charlotte

US001, West Palm Beach

US020, Atlanta

US048, Kailua

US030, Chicago

US051, Joliet

US040, Indianapolis

US036, Freeport

US032, Newton

US035, Kalamazoo

US041, Flowood

US054, St Louis

US046, Princeton

US028, Toms River

US044, Toms River

US049, Albany

US010, Amherst

US014, Manhasset

US008, New York

US029, New York

US056, New York

US037, Orangeburg

US043, Staten Island

US007, Centerville

US006, Columbus

US052, Edmond

US026, Portland

US057, Jenkintown

US047, Arlington

US025, Madison

US004, Milwaukee

AR002, Buenos Aires

AR003, Buenos Aires

AR006, Buenos Aires

AR007, Buenos Aires

AR009, Córdoba

AR004, Mar del Plata

AR005, Mendoza

AR008, Mendoza

AR010, Rosario

BE003, Bruges

BE002, Brussels

BE004, Brussels

BE005, Leuven

BE001, Roeselare

BE006, Thuin

BG005, Plovdiv

BG001, Sofia

BG002, Sofia

BG003, Sofia

BG004, Sofia

BG006, Sofia

BG007, Varna

CA002, Gatineau

CA006, London

CA008, Newmarket

CA001, Toronto

CA004, Toronto

CL004, Antofagasta

CL002, Santiago

CL003, Santiago

CL005, Santiago

CL001, Valdivia

CZ006, Brno

CZ007, Kutná Hora

CZ004, Pardubice

CZ001, Prague

CZ002, Prague

CZ003, Prague

CZ005, Rychnov nad Kněžnou

DK003, Aarhus N

DK001, Copenhagen

DK002, Odense C

FR006, Besançon

FR008, Limoges Cedex1

FR003, Nantes

FR001, Paris

FR005, Paris

FR004, Saint-Etienne

FR002, Toulouse

DE002, Berlin

DE006, Ellwangen

DE010, Günzburg

DE005, Hanover

DE007, Heidelberg

DE009, München

DE008, Ulm

DE004, Unterhaching

IT004, Ancona

IT006, Brescia

IT002, Florence

IT005, Genoa

IT003, Lamezia Terme

IT001, Milan

IT007, Palermo

PL004, Gliwice

PL007, Katowice

PL005, Poznan

PL006, Sopot

PL002, Szczecin

PL003, Warsaw

PL008, Wroclaw

RO002, Bucharest

RO001, Târgu Mureş

ZA003, Bloemfontein

ZA006, Cape Town

ZA007, Cape Town

ZA004, George

ZA005, Port Elizabeth

ZA001, Pretoria

ZA002, Rosebank

ES002, Alicante

ES006, Barcelona

ES001, Donostia / San Sebastian

ES005, Manresa

ES004, Salamanca

ES003, Santiago de Compostela

UA008, Dnipropetrovsk

UA006, Kherson,Vil. Stepanivka

UA005, Kyiv

UA007, Kyiv

UA001, Lviv

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

H. Lundbeck A/S

INDUSTRY